BILAYER THERAPEUTICS
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
BILAYER THERAPEUTICS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.bilayer-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
734-358-9015
Email Addresses:
[email protected]
Total Funding:
2 M USD
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Thrombolytic Science International
Thrombolytic Science International develops a clot-dissolving therapy for stroke and other thrombotic diseases.
Tiaki Therapeutics
Tiaki Therapeutics is committed to developing microglia-targeted therapeutics for the treatment of dementias.
Via Nova Therapeutics
Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Investors List
Kendall Capital Partners
Kendall Capital Partners investment in Venture Round - Bilayer Therapeutics
Official Site Inspections
http://www.bilayer-therapeutics.com
Unable to get host informations!!!
More informations about "Bilayer Therapeutics"
Bilayer Therapeutics - First-in-Class Treatment for Colonic Disorders
Bilayer Therapeutics is a development-stage company founded in 2020 by a team of world-renowned drug development and delivery experts and gastroenterologists to stimulate the …See details»
Bilayer Therapeutics - Crunchbase Company Profile
Organization. Bilayer Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Bilayer Therapeutics - LinkedIn
Bilayer Therapeutics is a development-stage company founded by a team of world-renowned drug development and delivery experts and gastroenterologists.See details»
Bilayer Therapeutics, Inc. | BioPharm America - Informa Connect
Bilayer Therapeutics, Inc. Profile. Company/Organization Description. Bilayer Therapeutic, Inc. was formed to develop BL-010, a bile acid-based, first-in-class therapeutic for constipation and …See details»
Bilayer Therapeutics 2025 Company Profile: Valuation, …
Bilayer Therapeutics was founded in 2020. Where is Bilayer Therapeutics headquartered? Bilayer Therapeutics is headquartered in Cambridge, MA. …See details»
Bilayer Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Bilayer Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Endocrinology and Metabolic Disease, Nervous System ...See details»
Bilayer Therapeutics - Contacts, Employees, Board Members
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. ... Experience the new Crunchbase, powered by …See details»
BILAYER THERAPEUTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BILAYER THERAPEUTICS, INC. of Cambridge, MA. Get the latest business insights from Dun & …See details»
Bilayer Therapeutics - Updates, News, Events, Signals & Triggers
Bilayer Therapeutics is focused on developing solid forms of sodium chenodeoxycholate (NaCDC) for therapeutic use. This involves creating compositions and methods for using and preparing …See details»
Bilayer Therapeutics - The Org
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.The company was founded in 2020 and is …See details»
Bilayer Therapeutics - Company Profile - Tracxn
Oct 19, 2024 Bilayer Therapeutics ranks 80th among 101 active competitors. 30 of its competitors are funded while 28 have exited. Overall, Bilayer Therapeutics and its competitors …See details»
Bilayer Therapeutics, Inc. - VentureRadar
Similar Companies: Intract Pharma United Kingdom Privately Held Intract is a licensing and product development company offering state-of-art formulation technologies for oral drug delivery of biologics and small molecules. Soteria® is a revolutionary new technology that allows patients to take biopharmaceutical drugs, including monoclonal antibodies, as a simple and safe tablet …See details»
Privacy Policy - Bilayer Therapeutics
Bilayer Therapeutics, Inc. is the operator of this website (“Bilayer,” “we” and “us”) and we care about your privacy. ... Also, as noted above, your registration may be controlled by your employer or another organization that you are affiliated with. Marketing .See details»
Thomas A. Collet, PhD - Bilayer Therapeutics
Thomas Collet is a serial life sciences entrepreneur with deep drug development expertise. He serves as President, CEO and Director of Bilayer Therapeutics. Dr. Collet has founded and led …See details»
Bilayer Therapeutics - workinbiotech.com
Ilayer Therapeutics, a development-stage biotech company, provides a novel approach to developing treatments for gastrointestinal disease and metabolic disorder. They were founded …See details»
Bilayer Therapeutics - Raised $2.3M Funding from 2 investors
Feb 24, 2025 Bilayer Therapeutics has raised a total funding of $2.3M over 2 rounds from 2 investors. Investors include Diamond Biofund and Kendall Capital Partners. Their latest …See details»
Bilayer Therapeutics - Overview, News & Similar companies
Bilayer Therapeutics contact info: Phone number: (734) 358-9015 Website: www.bilayer-therapeutics.com What does Bilayer Therapeutics do? Bilayer Therapeutics is a biotech …See details»
Bilayer Therapeutics, Inc. (Bilayer Therapeutics, Inc.) - 药物管线_ …
了解Bilayer Therapeutics, Inc. (Bilayer Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:内分泌与代谢疾病，神经系统疾病，技术平台:小分子化药，药物:BL-010 (Bilayer Therapeutics)，BL-050，BL-030，BL-040，BL-020。See details»
Bilayer Therapeutics, Inc. | CipherBio
Explore Bilayer Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Bilayer Therapeutics on LinkedIn: New Guidelines Underscore …
Bilayer Therapeutics reposted this Report this post Bilayer Therapeutics 208 followers 1y New Guidelines Underscore How Complicated Childhood Obesity Is for Patients and Providers ...See details»